Literature DB >> 18697783

Anti-collagen type II antibodies in patients with very early synovitis.

K Raza, M Mullazehi, M Salmon, C D Buckley, J Rönnelid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18697783      PMCID： PMC3119450          DOI： 10.1136/ard.2007.084277

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.

Authors:  Mohammed Mullazehi; Linda Mathsson; Jon Lampa; Johan Rönnelid
Journal:  Ann Rheum Dis       Date:  2006-10-13       Impact factor: 19.103

2.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

3.  Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.

Authors:  J Rönnelid; M C Wick; J Lampa; S Lindblad; B Nordmark; L Klareskog; R F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

4.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

5.  Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

Authors:  A D Cook; M J Rowley; I R Mackay; A Gough; P Emery
Journal:  Arthritis Rheum       Date:  1996-10

6.  Anti-cartilage antibody.

Authors:  C L Greenbury; J Skingle
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

7.  Antibodies against native type II collagen do not precede the clinical onset of rheumatoid arthritis.

Authors:  T Möttönen; P Hannonen; M Oka; J Rautiainen; I Jokinen; H Arvilommi; T Palosuo; K Aho
Journal:  Arthritis Rheum       Date:  1988-06

8.  Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis.

Authors:  Karim Raza; Mike Breese; Peter Nightingale; Kanta Kumar; Tanya Potter; David M Carruthers; Deva Situnayake; Caroline Gordon; Christopher D Buckley; Mike Salmon; George D Kitas
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

9.  Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.

Authors:  Karim Raza; Francesco Falciani; S John Curnow; Emma J Ross; Chi-Yeung Lee; Arne N Akbar; Janet M Lord; Caroline Gordon; Christopher D Buckley; Mike Salmon
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156
  9 in total
  2 in total

Review 1.  Of mice and men: how animal models advance our understanding of T-cell function in RA.

Authors:  Tamás Kobezda; Sheida Ghassemi-Nejad; Katalin Mikecz; Tibor T Glant; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-01-07       Impact factor: 20.543

2.  Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.

Authors:  M P M Vierboom; E Breedveld; Y S Kap; C Mary; N Poirier; B A 't Hart; B Vanhove
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.